Global Information
회사소개 | 문의

결핵 진단 시장 : 성장, 동향, 예측(2019-2024년)

Tuberculosis Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)

리서치사 Mordor Intelligence LLP
발행일 2019년 03월 상품 코드 659354
페이지 정보 영문 115 Pages
가격
US $ 4,250 ₩ 4,859,000 PDF by E-mail (Single User License)
US $ 4,500 ₩ 5,145,000 PDF by E-mail (Team License: Up to 5 Users)
US $ 7,000 ₩ 8,003,000 PDF by E-mail (Site License)
US $ 8,750 ₩ 10,004,000 PDF by E-mail (Corporate License)


결핵 진단 시장 : 성장, 동향, 예측(2019-2024년) Tuberculosis Diagnostics Market - Growth, Trends, and Forecast (2019 - 2024)
발행일 : 2019년 03월 페이지 정보 : 영문 115 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 결핵 진단(Tuberculosis Diagnostics) 시장을 조사했으며, 전체적인 시장 동향, 제품 및 지역별 동향, 시장 성장 영향요인, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

  • 시장 정의

제2장 조사 방법

제3장 주요 요약

제4장 주요 영향요인

제5장 시장 개요

  • 현재의 시장 시나리오
  • Porter's Five Forces 분석
    • 공급업체의 협상력
    • 소비자의 협상력
    • 신규 진출기업의 위협
    • 대체 제품 및 서비스의 위협
    • 업계 내 경쟁
  • 파이프라인 분석
  • 규제 프레임워크

제6장 성장 촉진요인 및 저해요인, 기회, 과제 분석(DROC)

  • 시장 성장 촉진요인
    • 결핵과 다제내성 결핵(MDR-TB)의 부담 증가
    • 연구개발(R&D) 투자와 집중형 제품 파이프라인 증가
    • 신흥 시장에서의 정부 정책 증가와 의식 고양
  • 시장 성장 저해요인
    • 결핵 진단에 따른 고비용
    • 신흥 시장에서의 보험 부족 또는 부재
  • 시장 기회
  • 주요 과제

제7장 시장 세분화

  • 진단 테스트 유형별
    • 방사선 검사
    • 실험실 시험
    • 핵산 검사
    • 사이토카인(Cytokine) 검출 시험
    • 약물 내성 시험
    • 기타
  • 최종사용자
    • 병원/클리닉
    • 진단/연구 실험실
    • 기타
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 중동 및 아프리카
    • 남미

제8장 경쟁 구도

  • 인수합병(M&A) 분석
  • 합의, 협력, 제휴
  • 신제품 발매

제9장 주요 기업

  • Abbott
  • Becton, Dickinson and Company
  • BioMerieux SA
  • Cepheid
  • F. Hoffmann-La Roche AG
  • Hain Lifescience GmbH
  • Hologic Corporation
  • Qiagen
  • Siemens
  • Thermo Fisher Scientific Inc.

제10장 시장 전망

LSH 18.07.17

Market Overview

The tuberculosis diagnostics market has witnessed a CAGR of 4.56%. Factors propelling the growth of the market include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets.

The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to WHO's Global TB Programme, it has implemented a systematic and dynamic process, that is used to evaluate technologies and develop policies, which has, thus, enhanced the growth of the market.

The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that are influencing people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period.

The market is also expected to witness growth as there is an opportunity for players in the market studied to accelerate the market approval of their pipeline diagnostic products by spurring the fundamental research in TB. Additionally, technological developments in fields, like genomics and proteomics, can be leveraged by diagnostic providers to hasten the process of product development in TB diagnostics.

Scope of the Report

Tuberculosis (TB) is a disease affecting the population across the world. Although tuberculosis is a curable disease, it still remains one of the most common causes of death among adults, particularly in emerging economies. The government initiatives for promoting diagnoses in TB are increasing globally, as governments of various regions are beginning to understand the gap areas in TB management.

Key Market Trends

Nucleic Acid Testing is expected to hold its Highest Market Share among the Diagnostic Tests

In the application type segmentation of the tuberculosis diagnostics market nucleic acid testing is believed to have the largest market size, and is expected to witness a CAGR of 5.4% during the forecast period. This can be attributed to the nucleic acid amplification tests (NAATs) that have been used as diagnostic tools for tuberculosis (TB) in the United States since many years, and which still continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, hese tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests, and even provide greater speed than culture-based tests.

The smear laboratory test is also highly specific in areas with a very high prevalence of tuberculosis. Further, the increasing prevalence rate of TB and advancements in culture-based tests are also expected to drive the market during the forecast period.

Asia-Pacific is the Largest Regional Tuberculosis Diagnostics Market and is expected to be the Same in the Forecast Period

Asia-Pacific is anticipated to exhibit profitable growth over the forecast period due to its high burden as well the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the growth of the TB diagnostics market, as the high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease.

In addition, according to the recent budget announcement, Government of India aims to eliminate tuberculosis (TB) by 2025, which is expected to act as a major factor for the growth of the Asia-Pacific market during the forecast period.

Competitive Landscape

The new product launches, collaborations, mergers and acquisitions, and regional expansions are the key strategic initiatives undertaken by these industry players. The major global players in the tuberculosis diagnostics market are Abbott, Becton, Dickinson and Company, BioMA©rieux SA, Cepheid, and F. Hoffmann-La Roche AG, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Burden of Tuberculosis and Multidrug-resistant Tuberculosis (MDR-TB)
    • 4.2.2 Increasing R&D Investments and Intensive Product Pipelines
    • 4.2.3 Increasing Government Initiatives and Rising Awareness in the Emerging Markets
  • 4.3 Market Restraints
    • 4.3.1 High Costs Associated with Tuberculosis Diagnostics
    • 4.3.2 Low Coverage or Absence of Insurance in the Emerging Markets
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Diagnostic Test Type
    • 5.1.1 Radiographic Test
    • 5.1.2 Laboratory Test
    • 5.1.3 Nucleic Acid Testing
    • 5.1.4 Cytokine Detection Test
    • 5.1.5 Drug Resistance Test
    • 5.1.6 Other Diagnostic Test Types
  • 5.2 By End User
    • 5.2.1 Hospital/Clinics
    • 5.2.2 Diagnostics/Research Laboratory
    • 5.2.3 Other End Users
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East & Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East & Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Becton, Dickinson and Company
    • 6.1.3 BioMerieux SA
    • 6.1.4 Cepheid
    • 6.1.5 F. Hoffmann-La Roche AG
    • 6.1.6 Hain Lifescience GmbH
    • 6.1.7 Hologic Corporation
    • 6.1.8 Qiagen
    • 6.1.9 AdvaCare Pharma
    • 6.1.10 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top
전화 문의
F A Q
 
BCC Research